Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Research
Paul Allen research foundation unveils with $500M funding plan
Based in Seattle, the new foundation is kicking off with grants for trials run by Seattle Children’s and Fred Hutchinson Cancer Center.
Darren Incorvaia
Aug 27, 2025 11:59am
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Aug 27, 2025 8:10am
Lineage tunes up hearing loss transplant with $12M research pact
Aug 26, 2025 11:00am
Cell therapy biotech Appia shuts down as funding runs dry
Aug 25, 2025 5:55pm
Arena BioWorks, 19 months after splashy launch, lays off staff
Aug 22, 2025 10:05am
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
Aug 21, 2025 10:52am